HANDS-ON IMPACTIN GERMANYMArSIN SWITZERLANDSWIZZARDIN AUSTRIAsupersonic
HANDS-ON IMPACTIN GERMANYMArSIN SWITZERLANDSWIZZARDIN AUSTRIAsupersonic
DACH Region
The most attractive healthcare market in Europe
Best performing healthcare systems in the heart of Europe (political stability, attractive price point, high GDP, low unemployment rate)
- Similar culture and German as a common language
- Functional healthcare systems (broad access to pharmaceutical products and high expenditures per capita)
- High research and development budgets and innovation rankings
SMS2DACH Partners
Switzerland
Swizzard Pharma AG is a provider of support services for biotech and pharma companies in Switzerland. As part of the company’s mission to enable healthy lives in Switzerland, Swizzard helps clients maximize the value of their breakthroughs in the Swiss market. Swizzard offers a range of services, drawing on vast experience and exceptional connections to deliver fast and lean settle-in, market preparation and commercialization solutions.
Germany
Are you looking for a hands-on consultancy with a strategic vision for the D-A-CH region? MArS has years of experience in planning, filing and negotiating in the three D-A-CH countries and will lead you successfully with your product to your commercial objective!
Austria
BOOST YOUR BUSINESS IN THE AUSTRIAN HEALTHCARE MARKET
You are looking for a competent partner in Austria? Look no further – you came to the right place!
Meet the team
Switzerland
Michael Zürcher, PhD EMBA
Germany
Dr. Stefan Walzer
Austria
Axel Binder
Dr. Alexander Knabl
Dr. Thorsten Peske
Dr. Matthias Cerha
Best performing healthcare systems
Switzerland
Strong European Headquarters ecosystem and large talent pool
High willingness to prescribe medical breakthroughs
Fast patient access opportunity through project ORBIS and article 71 KVV
Germany
Free pricing for drugs at launch
Pragmatic inpatient funding process
Fast track digital health reimbursement
Austria
Launch Market: Optimal conditions for early launch due to well financed healthcare system
Fast Track Access: EMA approval allows immediate access options to hospital and outpatient market
Early access: Austria is classified as a “Strong Innovator” by European Innovation Scoreboard
